Etamivan
|  | |
| Systematic (IUPAC) name | |
|---|---|
| N,N-diethyl-4-hydroxy-3-methoxybenzamide | |
| Clinical data | |
| Trade names | Analepticon | 
| Identifiers | |
| CAS Number | 304-84-7 | 
| ATC code | R07AB04 | 
| PubChem | CID 9363 | 
| DrugBank | DB08989  | 
| ChemSpider | 8996 | 
| UNII | M44O63YPV9  | 
| KEGG | D04080  | 
| Chemical data | |
| Formula | C12H17NO3 | 
| Molar mass | 223.268 g/mol | 
| 
 | |
| 
 | |
| (verify) | |
Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.
References
- ↑ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- ↑ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- ↑ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.
| 
 | ||||||||||||||||||
This article is issued from Wikipedia - version of the Thursday, January 15, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.